Showing results (161-170 of 181) with videos related to
Sort By:
Pageof 19
HIV Clinical Trials|October 30, 2003
A multi-investigator/institutional DNA bank for AIDS-related human genetic studies: AACTG Protocol A5128David W Haas, Grant R Wilkinson, Daniel R Kuritzkes, et al.Plos One|August 20, 2009
HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteinsZabrina L Brumme, Mina John, Jonathan M Carlson, et al.Scientific Reports|August 19, 2017
Shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk allelesRebecca Pavlos, Elizabeth J McKinnon, David A Ostrov, et al.Pharmacogenetics and Genomics|June 12, 2023
Pharmacogenetic interactions of efavirenz or rifampin and isoniazid with levonorgestrel emergency contraception during treatment of HIV or tuberculosisNana Agyemang, Kimberly K Scarsi, Paxton Baker, et al.Memorias Do Instituto Oswaldo Cruz|July 15, 2026
Determinants of HIV-1 virologic suppression in HIV-associated tuberculosis in BrazilFelipe Ridolfi, Gustavo Amorim, David W Haas, et al.Journal of Neurovirology|October 18, 2012
Mitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTEREmily R Holzinger, Todd Hulgan, Ronald J Ellis, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|June 27, 2023
Associations of Muscle Density and Area With Coronary Artery Plaque and Physical FunctionKristine M Erlandson, Triin Umbleja, Michael T Lu, et al.Nature Genetics|May 22, 2012
Extremely low-coverage sequencing and imputation increases power for genome-wide association studiesBogdan Pasaniuc, Nadin Rohland, Paul J McLaren, et al.American Journal of Human Genetics|January 5, 2010
Quantitative trait loci for CD4:CD8 lymphocyte ratio are associated with risk of type 1 diabetes and HIV-1 immune controlManuel A R Ferreira, Massimo Mangino, Chanson J Brumme, et al.Annals of Internal Medicine|October 7, 2014
Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trialJeffrey L Lennox, Raphael J Landovitz, Heather J Ribaudo, et al.Pageof 19